Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | RRM1 | P23921 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3910768 | 1.00 | CES2 (0.55) | CES2DNM1CES1RRM1MEN1 | |
| SCHEMBL7777074 | 1.00 | CES2 (0.55) | CES2DNM1CES1RRM1MEN1 | |
| SCHEMBL3914545 | 1.00 | CES2 (0.55) | CES2DNM1CES1RRM1MEN1 | |
| SCHEMBL5248007 | 1.00 | CES2 (0.55) | CES2DNM1CES1RRM1MEN1 | |
| SCHEMBL21061920 | 0.98 | CES2 (0.53) | CES2DNM1CES1RRM1MEN1 | |
| Acetic Acid SCHEMBL6261375 | 0.94 | CES2 (0.50) | CES2MEN1KMT2AALDH1A1TSHR | |
| Acetic Acid SCHEMBL468672 | 0.94 | CES2 (0.50) | CES2MEN1KMT2AALDH1A1TSHR | |
| Acetic Acid SCHEMBL1987108 | 0.93 | CES2 (0.48) | CES2MEN1KMT2AALDH1A1TSHR | |
| Acetic Acid SCHEMBL21049873 | 0.93 | CES2 (0.48) | CES2MEN1KMT2AALDH1A1TSHR | |
| Acetic Acid SCHEMBL8093379 | 0.93 | CES2 (0.48) | CES2MEN1KMT2AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3463582-B1 | BLEACHING AGENT AND METHOD FOR GENTLE OXIDATIVE HAIR LIGHTENING I | HENKEL AG & CO KGAA (DE) | 2020-12-30 | — | — | EP | claimed |
| CN-108822738-A | A kind of coloured glaze chemical polishing solution | 浙江千玉装饰科技股份有限公司 | 2018-11-16 | — | — | CN | claimed |
| CN-1658819-A | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | OREAL (FR) | 2005-08-24 | — | — | CN | claimed |
| EP-1515684-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2005-03-23 | — | — | EP | claimed |
| WO-2003105788-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2003-12-24 | — | — | WO | claimed |
| EP-1174110-A1 | Cosmetic or pharmaceutical solid composition comprising bis-acyl-amides | L'OREAL (FR) | 2002-01-23 | — | — | EP | claimed |
| US-12037541-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2024-07-16 | — | — | US | disclosed |
| US-11993743-B2 | Double-chamber microcapsule for drilling fluid and self-reversing reversible water-in-oil drilling fluid and preparation method thereof | SOUTHWEST PETROLEUM UNIVERSITY (CN) | 2024-05-28 | — | — | US | disclosed |
| US-20230357623-A1 | DOUBLE-CHAMBER MICROCAPSULE FOR DRILLING FLUID AND SELF-REVERSING REVERSIBLE WATER-IN-OIL DRILLING FLUID AND PREPARATION METHOD THEREOF | SOUTHWEST PETROLEUM UNIVERSITY (CN) | 2023-11-09 | — | — | US | disclosed |
| CN-114790379-A | Double-chamber microcapsule for drilling fluid and preparation method and application thereof | 西南石油大学 | 2022-07-26 | — | — | CN | disclosed |
| CN-114686187-A | Hairbrush-like amide lubricant and preparation method and application thereof | 中石化石油工程技术服务有限公司 | 2022-07-01 | — | — | CN | disclosed |
| US-20220033705-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2022-02-03 | — | — | US | disclosed |
| US-11186764-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2021-11-30 | — | — | US | disclosed |
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | L'OREAL (FR) | 2003-05-15 | — | — | US | disclosed |
| EP-1264589-A1 | Use of a polar additive in a cosmetic composition containing a structured liquid oil phase by at least one organogelator to give a thixotropic character | L'OREAL (FR) | 2002-12-11 | — | — | EP | disclosed |
| WO-2002005763-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION IN SOLID FORM COMPRISING BIS-ACYL-AMIDES | L'OREAL (FR) | 2002-01-24 | — | — | WO | disclosed |
| EP-1174110-A1 | Cosmetic or pharmaceutical solid composition comprising bis-acyl-amides | L'OREAL (FR) | 2002-01-23 | — | — | EP | disclosed |
| EP-0948540-A2 | METHOD FOR SOLUBILIZATION AND NATURATION OF SOMATOTROPINS | MONSANTO COMPANY (US) | 1999-10-13 | — | — | EP | disclosed |
| WO-1998029433-A3 | METHOD FOR SOLUBILIZATION AND NATURATION OF SOMATOTROPINS | MONSANTO CO (US) | 1998-10-15 | — | — | WO | disclosed |
| WO-1998029433-A2 | METHOD FOR SOLUBILIZATION AND NATURATION OF SOMATOTROPINS | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037541-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | LIPA, SGMS1, AQP1 | CES2 1086/4885DNM1 498/4885CES1 550/4885 |
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | PLIN3, CUTA, FABP4 | CES2 3238/4885DNM1 4119/4885CES1 612/4885 |
| US-11186764-B2 | Anionic-cationic-nonionic surfactant, production and use thereof | LIPA, ABHD12, ABHD16A | CES2 928/4885DNM1 661/4885CES1 1037/4885 |
| US-20220033705-A1 | ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF | LIPA, ABHD16A, ABHD12 | CES2 791/4885DNM1 705/4885CES1 645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.